List of New Drugs Approved for Marketing in India: CDSCO

List of New Drugs Approved for Marketing in India
Year 2013
Year 2012
Year 2011
Year 2010
Year 2009
Year 2008
Year 2007
Year 2006
Year 2005
Year 2004
Year 2003
Year 2002
Year 2001
Year 2000
Year 1999
Year 1971-1998

Drug Patent Expirations for March 2014

Drug Patent Expirations for March 2014 Tradename Applicant Generic Name Patent No. EVISTA Lilly raloxifene hydrochloride 5,478,847 EVISTA Lilly raloxifene hydrochloride RE39050 EVISTA Lilly raloxifene hydrochloride 5,972,383 EVISTA Lilly raloxifene hydrochloride 5,811,120 AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER Bayer Hlthcare moxifloxacin hydrochloride 5,607,942 EMEND Merck And Co Inc fosaprepitant dimeglumine 5,512,570 AVELOX Bayer Hlthcare moxifloxacin hydrochloride 5,607,942 EXUBERA Pfizer insulin recombinant human 5,997,848 EXUBERA Pfizer insulin recombinant human 6,592,904 EXUBERA Pfizer insulin recombinant human 6,051,256 EXUBERA Pfizer insulin recombinant human 6,737,045 EXUBERA Pfizer insulin recombinant human 6,423,344 IMITREX Glaxosmithkline sumatriptan 5,554,639*PED KALETRA Abbvie lopinavir; ritonavir 5,948,436*PED NORVIR Abbvie ritonavir 5,948,436*PED NORVIR Abbott ritonavir 5,948,436*PED ACCOLATE Astrazeneca zafirlukast 5,612,367 LIPTRUZET Merck Sharp Dohme atorvastatin calcium; ezetimibe 5,846,966*PED ZETIA Msd Intl Gmbh ezetimibe 5,846,966*PED VYTORIN Msd Intl ezetimibe; simvastatin 5,846,966*PED MONISTAT 1 COMBINATION PACK Insight Pharms miconazole nitrate 5,514,698 ZORTRESS Novartis everolimus 6,440,990*PED RAPAMUNE Pf Prism Cv sirolimus 5,536,729*PED BUSULFEX Otsuka Pharm busulfan 5,430,057*PED LIDODERM Teikoku Pharma Usa lidocaine 5,741,510 BUSULFEX Otsuka Pharm busulfan 5,559,148*PED *Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.